Furthermore, KEGG pathway enrichment supported these observations by demonstrating that the drug target genes are predominantly enriched in cancer-related pathways, particularly the PI3K-Akt, MAPK, and Ras signaling pathways, which are well-known for regulating cell growth, survival, and apoptosis (see Figure 5). This evidence concerns the gene AKT1 and cancer.